| Ytd | 18.90% | |
| 1y | 19.87% |
| Open | 178.35 | Prev Close | 179.63 | Low | 178.35 | High | 181.79 | Mkt Cap | 49.99B |
| Vol | 0.00 | Avg Vol | 2.49M | EPS | 13.00 | P/E | 13.95 | Forward P/E | 13.48 |
| Beta | 0.26 | Short Ratio | 3.74 | Inst. Own | 101.92% | Dividend | 4.20 | Div Yield | 2.37 |
| Ex Div Date | 09-09 | Earning | 08-06 | 50-d Avg | 154.86 | 200-d Avg | 155.84 | 1yr Est | 192.00 |
About a year ago, 24/7 Wall St. flagged four overlooked Dividend Aristocrats as stealth growth plays
Revenue: $5 billion, up 4.4% on an FX-neutral basis.Adjusted Operating Margin: 24.9%, down 130 basis
Becton, Dickinson and Company NYSE: BDX reported third-quarter fiscal 2026 revenue of $5 billion, up
Citigroup analyst Joanna Wiensch maintains Becton Dickinson (NYSE:BDX) with a Buy and raises the
RBC Capital analyst Kendall Au maintains Becton Dickinson (NYSE:BDX) with a Sector Perform and ra
Piper Sandler analyst Jason Bednar maintains Becton Dickinson (NYSE:BDX) with a Neutral and raise
Wells Fargo analyst Lawrence Biegelsen maintains Becton Dickinson (NYSE:BDX) with a Equal-Weight
BDX tops third-quarter fiscal 2026 earnings and revenue estimates as broad segment growth offset pre
Becton, Dickinson and Company (BDX) Q3 2026 Earnings Call Transcript
Becton, Dickinson and Co (NYSE:BDX) on Thursday reported third-quarter adjusted earnings of $3.23 pe
Becton Dickinson raises 2026 adjusted EPS guidance after reporting Q3 revenue growth across core med
The headline numbers for Becton Dickinson (BDX) give insight into how the company performed in the q
Becton Dickinson (BDX) came out with quarterly earnings of $3.23 per share, beating the Zacks Consen
Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.23 per share which beat the analyst c
Becton Dickinson (NYSE:BDX) raises FY2026 Adj EPS guidance from $12.52-$12.72 to $12.62-$12.72 vs $1
Revenue of $5.0 billion increased 5.4% as reported, 4.4% FXN GAAP and adjusted diluted EPS from cont
BDX's Medical Essentials and Interventional strength may drive third-quarter fiscal 2026 results, bu
TD Cowen analyst Joshua Jennings maintains Becton Dickinson (NYSE:BDX) with a Hold and raises the
Evaluate the expected performance of Becton Dickinson (BDX) for the quarter ended June 2026, looking
Becton Dickinson said on Friday it is issuing a recall on certain lots of medical needle sets in the
They may profit from the rapidly growing GLP-1 market in very different ways.
Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a
FRANKLIN LAKES, N.J., July 28, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson
UBS analyst Patrick Wood initiates coverage on Becton Dickinson (NYSE:BDX) with a Buy rating and
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise doub
FRANKLIN LAKES, N.J., July 22, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),
Here's a 2.7% dividend yield that has been growing by 10%-plus annually -- and it's undervalued, too
FRANKLIN LAKES, N.J., July 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a
Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right
U.S. stocks are little changed on Tuesday, but the Dow Jones Industrial Average is stealing the spot
Market sentiment increased as stocks settled higher on Friday, with Dow Jones reaching 50,000 points
The FDA clears Becton Dickinson's EnCor EnCompass breast biopsy system, with a U.S. launch plann
A fund manager who beats 99% of his peers calls Tesla stock overvalued. Here's a look at some of
U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from Pres
Elevance Health and Waters led the weekly large-cap losers, hit by weak earnings, lowered guidance,
The stock markets is in a lackluster session on Thursday, with traders eagerly awaiting more clues o
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin